Rewriting the script: time to rethink the indications for myoma surgery


Like Comment

Volume 107, Issue 2, Pages 334–335


Jacques Donnez, M.D., Ph.D., Olivier Donnez, M.D., Ph.D., Marie-Madeleine Dolmans, M.D., Ph.D.


Uterine fibroids, the most frequently encountered benign uterine tumors, have a profound impact on the quality of life (QOL) of patients. Moreover, they are associated with a considerable societal burden due to the direct costs of treatment and the indirect costs linked to work absenteeism. Around 30% of women with leiomyomas will request treatment because of severe heavy menstrual bleeding, abdominal pain, bulk symptoms, and/or infertility.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.